TrkB agonist, 7,8-dihydroxyflavone, reduces the clinical and pathological severity of a murine model of multiple sclerosis. Makar TK, Nimmagadda VKC, Singh IS, Lam K, Mubariz F, Judge SIV, Trisler D, Bever CT J Neuroimmunol. 2016 Mar 15; 292:9-20. Epub 2016 Jan 06. PMID: 26943953. Abstract CommentRecommendBookmarkWatch